Article
inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice.
Blood - 27 Oct 2016
Ellegast Jana M, Rauch Philipp J, Kovtonyuk Larisa V, Müller Rouven, Wagner Ulrich, Saito Yasuyuki, Wildner-Verhey van Wijk Nicole, Fritz Christine, Rafiei Anahita, Lysenko Veronika, Dudkiewicz Ewa, Theocharides Alexandre P, Soldini Davide, Goede Jeroen S, Flavell Richard A, Manz Markus G
Abstract excerpt
Favorable-risk human acute myeloid leukemia (AML) engrafts poorly in currently used immunodeficient mice, possibly because of insufficient environmental support of these leukemic entities. To address this limitation, we here transplanted primary human AML with isolated nucleophosmin (NPM1) mutation and AML with inv(16) in mice in which human versions of genes encoding cytokines important for myelopoiesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
